I

IO Biotech
D

IOBT

1.09000
USD
-0.02
(-1.80%)
مغلق
حجم التداول
228
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
71,810,196
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: IO Biotech

القطاع: Healthcare
الصناعة: Biotechnology
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.